Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study (Q74799740)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 1997
edit
Language Label Description Also known as
English
Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study
scientific article published on 01 January 1997

    Statements

    Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit